TwoStep Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TwoStep Therapeutics, Inc. - overview
Established
2023
Location
San Carlos, CA, US
Primary Industry
Biotechnology
About
Founded in 2023 by Caitlyn Miller (CEO), Jennifer Cochran, Ronald Levy, and Carolyn Bertozzi, and based in California, US, TwoStep Therapeutics, Inc. is a biotechnology company that develops and offers targeted therapies across various solid tumors. In June 2024, TwoStep Therapeutics, Inc. raised USD 6.
5 million in seed funding led by NFX, with participation from 2048 Ventures, Alexandria Venture Investments, Cooley's affiliated fund GC&H Investments, and the Family office of the founder of Arcadia Investment Partners. The company aims to improve cancer treatment by extending precision medicines to a wider range of tumor types and patient populations with limited options. Their approach involves the use of clinically validated cytotoxic payloads and immunotherapy leveraging the modular PIP that offers multi-specific targeting to offer cancer therapies. The company intends to use the June 2024 funding to advance TwoStep's therapeutic pipeline of solid tumor-targeting therapies and initial focus on targeted cytotoxic drug delivery and immunotherapy.
Current Investors
Alexandria Venture Investments, GC&H Investments, NFX
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biotechnology, Oncology/Cancer Treatment
Website
www.twosteptx.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.